Please wait while the formulary information is being retrieved.
ARCALYST (RILONACEPT)
- Familial cold autoinflammatory syndrome
- Muckle-wells syndrome
220 mg subcutaneous solution
- Inject 2 milliliters (160 mg) by subcutaneous route once weekly
Familial cold autoinflammatory syndrome
- Inject 2 milliliters (160 mg) by subcutaneous route once weekly
Muckle-wells syndrome
- Inject 2 milliliters (160 mg) by subcutaneous route once weekly
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- adalimumab
- certolizumab pegol
- Cimzia
- Cimzia Powder For Reconst
- Cimzia Starter Kit
- Enbrel
- Enbrel Sureclick
- etanercept
- golimumab
- Humira
- Humira Crohn's Dis Start Pck
- Humira Pen
- Humira Psoriasis Starter Pack
- infliximab
- Remicade
- Simponi
- Simponi Aria
Severe
Moderate
- None
- None
Contraindicated
- Infection
Severe
Moderate
- Hypercholesterolemia
- Hypertriglyceridemia
ARCALYST (RILONACEPT)
- Familial cold autoinflammatory syndrome
- Muckle-wells syndrome
- None
- Cough
- Hypesthesia
- Injection site sequelae
- Upper respiratory infection
More Frequent
Severe
Less Severe
- Infection
- Sinusitis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Colitis
- Gastrointestinal hemorrhage
- Hypercholesterolemia
- Hypertriglyceridemia
- Malignancy
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Rilonacept
- Severity Level:
C
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Rilonacept
Caution advised; insufficient data available.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Caution advised; insufficient data available. |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Familial cold autoinflammatory syndrome | |
| M04.2 | Cryopyrin-associated periodic syndromes |
| Muckle-wells syndrome | |
| M04.2 | Cryopyrin-associated periodic syndromes |
| 0-9 | A-Z |
|---|---|
| M04.2 | Cryopyrin-associated periodic syndromes |
| M04.2 | Cryopyrin-associated periodic syndromes |
Formulary Reference Tool